AR021419A1 - El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos - Google Patents

El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos

Info

Publication number
AR021419A1
AR021419A1 ARP990106045A ARP990106045A AR021419A1 AR 021419 A1 AR021419 A1 AR 021419A1 AR P990106045 A ARP990106045 A AR P990106045A AR P990106045 A ARP990106045 A AR P990106045A AR 021419 A1 AR021419 A1 AR 021419A1
Authority
AR
Argentina
Prior art keywords
group
compounds
substituted
groups
partial formulas
Prior art date
Application number
ARP990106045A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR021419A1 publication Critical patent/AR021419A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Abstract

El empleo de compuestos no esteroides para la preparacion de medicamentos con efecto antiinflamatorio, compuestos que responden a la formula general (1),en donde: R1 y R2 son iguales o diferentes y representan un átomo de hidrogeno, un grupo alquiloC1-5 o, junto al átomo de C de la cadena, representan unanillo que en total tiene de 3 a 7 miembros; R3 representa un grupo alquilo C1-5 parcialmente o totalmente fluorado; A representa el grupo de formula (6) donde(la línea punteada significa una ligadura), en el cual R4 representa un átomo de hidrogeno, un grupo alquilo C1-5, un grupo acilo C1-10, un grupocarbalcoxialquilo C3-10, un grupo cianoalquilo C2-5, un grupo alilo C3-10 sustituido o sustituido, un grupo propargilo C3-10 sustituido o nosustituido, ungrupo alcoxialquilo C2-5, un grupo alquilo C1-5 parcialmente o totalmente sustituido con átomos de fluor; R5 a R8 son iguales o diferentes y se eligen delgrupo formado por los átomos de hidrogeno, los átomos de halogeno y los grupos alcoxi C1-5, y R4 y R5, juntos, también representan un anillo heterocíclico queen total tiene de 5 a 7 miembros y que, además del átomo de oxígeno, puede contener eventualmente al menos otro heteroátomo del grupo formado por el oxígeno,el nitrogeno y el azufre; B representa un grupo carbonilo o un grupo CH2; y Ar representa un sistema de anillos elegido del grupo de las formulas parciales (2)a (5), en donde los restos X3a, X3b, X4, X6, X7 (en las formulas parciales (2) y (3)) e Y4, Y5, Y7, Y8 (enlas formulas parciales (4) y (5)) son iguales odiferentes y se eligen entre los átomos de hidrogeno, los grupos aluilo C1-5, los grupos alquilo C1-5 parcialmente o totalmente fluorados, y además, los restosX4, X6, X7 (de las formulas parciales (2) y(3)) o los restos Y5, Y7, Y8 (en las formulas parciales (4) y (5)) se eligen entre los átomos de halogeno, losgrupos hidroxilo, los grupos alcoxi C1-5 o los grupos alcanoiloxi C1-5, y, para el caso en que B representa un grupo CH2, también se empleansales, aceptablesdesde el punto de vista fisiologico, de los compuestos de la formula general (1) que se forman por agregados de ácidos. Los preparados farmacéuticos que
ARP990106045A 1998-11-27 1999-11-26 El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos AR021419A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19856475A DE19856475A1 (de) 1998-11-27 1998-11-27 Nichtsteroidale Entzündungshemmer

Publications (1)

Publication Number Publication Date
AR021419A1 true AR021419A1 (es) 2002-07-17

Family

ID=7890303

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106045A AR021419A1 (es) 1998-11-27 1999-11-26 El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos

Country Status (31)

Country Link
US (1) US6323199B1 (es)
EP (1) EP1133486B1 (es)
JP (1) JP2002531446A (es)
KR (1) KR100762058B1 (es)
CN (1) CN1171883C (es)
AR (1) AR021419A1 (es)
AT (1) ATE285405T1 (es)
AU (1) AU762735B2 (es)
BG (1) BG65030B1 (es)
BR (1) BR9915755A (es)
CA (1) CA2352367A1 (es)
CO (1) CO5140109A1 (es)
CZ (1) CZ20011866A3 (es)
DE (2) DE19856475A1 (es)
EA (1) EA003299B1 (es)
EE (1) EE200100283A (es)
ES (1) ES2235543T3 (es)
HK (1) HK1043592B (es)
HR (1) HRP20010483B1 (es)
HU (1) HUP0104578A3 (es)
IL (2) IL143393A0 (es)
MY (1) MY136016A (es)
NO (1) NO20012562L (es)
NZ (1) NZ511950A (es)
PE (1) PE20001245A1 (es)
PL (1) PL348329A1 (es)
PT (1) PT1133486E (es)
SK (1) SK7212001A3 (es)
UA (1) UA73102C2 (es)
WO (1) WO2000032584A2 (es)
ZA (1) ZA200105280B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038639A1 (de) 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
US7238707B2 (en) * 2000-07-28 2007-07-03 Schering Ag Substituted pentanols, a process for their production and their use as anti-inflammatory agents
DE10346940B3 (de) * 2003-10-06 2005-06-16 Schering Ag Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
DE60228954D1 (en) * 2001-05-03 2008-10-30 Galileo Lab Inc Pyruvatderivate
CA2472746A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
ES2298508T3 (es) * 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
CA2477764A1 (en) * 2002-03-26 2003-10-09 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE10215316C1 (de) * 2002-04-02 2003-12-18 Schering Ag Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7186864B2 (en) * 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2496175A1 (en) * 2002-08-21 2004-03-04 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BR0313923A (pt) * 2002-08-29 2005-07-12 Boehringer Ingelheim Pharma Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
DE10261874A1 (de) * 2002-12-20 2004-07-08 Schering Ag Nichtsteroidale Entzündungshemmer
US7112584B2 (en) * 2002-12-20 2006-09-26 Schering Ag Nonsteroidal antiinflammatory agents
EP1583745A1 (en) * 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
WO2004071389A2 (en) * 2003-02-15 2004-08-26 Glaxo Group Limited Non-steroidal infalmmation inhibitors
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
MXPA06000169A (es) * 2003-07-01 2006-04-27 Schering Ag Derivados de pentanol heterociclicamente sustituidos, procedimiento para su preparacion y su uso como anti-inflamatorios.
US20050090559A1 (en) * 2003-07-01 2005-04-28 Markus Berger Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
DE10347385A1 (de) * 2003-10-08 2005-05-12 Schering Ag Umgelagerte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7507843B2 (en) * 2003-10-16 2009-03-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
GB0418045D0 (en) 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
JP2008525525A (ja) * 2004-12-27 2008-07-17 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物及び使用
JP2008543780A (ja) * 2005-06-10 2008-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルココルチコイド模倣薬、それらの製造方法、医薬組成物及びそれらの使用
DE102005030292A1 (de) * 2005-06-24 2007-01-11 Schering Ag Nichtsteroidale Progesteronrezeptor-Modulatoren
GB0513297D0 (en) * 2005-06-29 2005-08-03 Glaxo Group Ltd Novel compounds
CA2519010A1 (en) 2005-09-13 2007-03-13 Cognos Incorporated Query framework system and method
TW200815361A (en) * 2005-10-20 2008-04-01 Astrazeneca Ab Chemical compounds
GB0522880D0 (en) * 2005-11-09 2005-12-21 Glaxo Group Ltd Novel compounds
CN101326169B (zh) * 2005-12-09 2011-11-16 霍夫曼-拉罗奇有限公司 作为抗炎剂的糖皮质激素受体调节剂
EP1960351B1 (en) * 2005-12-09 2013-06-19 F.Hoffmann-La Roche Ag Propionamide compounds as antiinflammatory agents
WO2007120083A1 (en) * 2006-04-13 2007-10-25 Astrazeneca Ab The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
EA200801997A1 (ru) 2006-04-20 2009-04-28 Глаксо Груп Лимитед Новые соединения
GB0611587D0 (en) * 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
WO2008000777A2 (en) * 2006-06-29 2008-01-03 Glaxo Group Limited Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use
TW200829578A (en) 2006-11-23 2008-07-16 Astrazeneca Ab Chemical compounds 537
KR20090097908A (ko) * 2006-12-06 2009-09-16 베링거 인겔하임 인터내셔날 게엠베하 글루코코르티코이드 모사물, 이의 제조 방법, 이의 약제학적 조성물 및 용도
WO2008074814A1 (en) * 2006-12-20 2008-06-26 Glaxo Group Limited Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
JO2754B1 (en) * 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
MX2009008323A (es) * 2007-02-15 2009-08-13 Argenta Discovery Ltd Derivados heterociclicos como receptores muscarinicos m3.
US8211930B2 (en) * 2008-05-20 2012-07-03 Astrazeneca Ab Phenyl and benzodioxinyl substituted indazoles derivatives
SI2300472T1 (sl) * 2008-06-06 2012-05-31 Boehringer Ingelheim Int Glukokortikoidni mimetiki postopki za njihovo pripravo farmacevtski sestavki in njihove uporabe
GB0814729D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
AU2010280323A1 (en) 2009-07-31 2012-03-08 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
EP3569228A1 (en) 2018-05-17 2019-11-20 Association pour la recherche à l'IGBMC (ARI) Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
FI3700513T3 (fi) 2017-10-27 2022-12-15 Ei-steroidiset selektiiviset glukortikoidireseptorin agonistimodulaattorit (segramit) ja niiden käyttö

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261835A (en) 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
GB8617653D0 (en) 1986-07-18 1986-08-28 Ici Plc Amide derivatives
DE19723722A1 (de) 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene

Also Published As

Publication number Publication date
BG65030B1 (bg) 2006-12-29
HUP0104578A3 (en) 2003-01-28
AU1976000A (en) 2000-06-19
DE19856475A1 (de) 2000-05-31
BG105527A (en) 2002-02-28
US6323199B1 (en) 2001-11-27
EA003299B1 (ru) 2003-04-24
HK1043592A1 (en) 2002-09-20
UA73102C2 (en) 2005-06-15
HRP20010483B1 (en) 2007-08-31
NZ511950A (en) 2003-12-19
PT1133486E (pt) 2005-04-29
NO20012562D0 (no) 2001-05-25
CN1334809A (zh) 2002-02-06
AU762735B2 (en) 2003-07-03
EP1133486A2 (de) 2001-09-19
CA2352367A1 (en) 2000-06-08
EP1133486B1 (de) 2004-12-22
PE20001245A1 (es) 2000-11-08
HK1043592B (zh) 2005-06-03
WO2000032584A2 (de) 2000-06-08
ZA200105280B (en) 2002-06-26
KR100762058B1 (ko) 2007-10-04
EA200100529A1 (ru) 2001-12-24
ES2235543T3 (es) 2005-07-01
IL143393A (en) 2006-04-10
ATE285405T1 (de) 2005-01-15
CO5140109A1 (es) 2002-03-22
KR20010086055A (ko) 2001-09-07
NO20012562L (no) 2001-07-26
HRP20010483A2 (en) 2003-12-31
PL348329A1 (en) 2002-05-20
DE59911340D1 (de) 2005-01-27
CZ20011866A3 (cs) 2001-09-12
CN1171883C (zh) 2004-10-20
BR9915755A (pt) 2001-08-28
HUP0104578A2 (hu) 2002-04-29
WO2000032584A3 (de) 2000-11-09
MY136016A (en) 2008-07-31
EE200100283A (et) 2002-08-15
IL143393A0 (en) 2002-04-21
SK7212001A3 (en) 2003-02-04
JP2002531446A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
AR021419A1 (es) El empleo de compuestos no esteroides para preparar medicamentos antiinflamatorios, los compuestos no esteroides que son apropiados para este empleo y lospreparados farmaceuticos que contienen estos ultimos compuestos
DK1086706T3 (da) Stabiliserede sammensætninger indeholdende nootropiske lægemidler
AR063555A1 (es) Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos
SE8300736D0 (sv) Novel pharmacologically active compounds
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
AR016817A1 (es) Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
UY27457A1 (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
ATE504579T1 (de) Antivirale mittel
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
LU90366I2 (fr) Nasonex
ATE504294T1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
AR038686A1 (es) Formulaciones de derivados de androstano y agonistas del adrenoreceptor beta 2 antiinflamatorios
AR045906A1 (es) Composicion farmaceutica para mejorar la solubilidad de farmacos hidrofobicos
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
CO5590911A2 (es) Composiciones farmaceuticas a base de derivados de azetidina
DK1992338T5 (da) Farmaceutiske sammensætninger til oral administration af heparin eller derivater deraf
AR016551A1 (es) Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos
AR035465A1 (es) Compuestos de imidazopiridina, procesos para su preparacion,formulacion farmaceutica, usos de estos compuestos para la fabricacion de medicamentos e intermediarios
ATE137223T1 (de) Leukotrien-b4-antagonisten
AR021845A1 (es) Derivados de 1,3-diaril-2-piridin-2-il-3-(piridin-2-ilamino)-propanol sustituidos, composiciones farmaceuticas y medicamentos que las comprenden, procedimientos para su preparacion, medicamentos que contienen estos compuestos, y su utilizacion para la preparcion de medicamentos
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FB Suspension of granting procedure